GlassScriptPhysician profile
Micah D Hall
NPI 1194088484
$3,604.67
in general payments reported to CMS, 2019-2025
40 companies · $604 in 2025
The $604 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $499 · 2021: $563 · 2022: $516 · 2023: $548 · 2024: $377 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,529.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $404.05 | 2019-2025 | Otezla, Repatha, Evenity |
| Abbvie INC. | $388.64 | 2020-2025 | |
| Glaxosmithkline, LLC. | $315.49 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $290.37 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $273.43 | 2020-2025 | Veozah |
| Allergan, INC. | $160.41 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $148.90 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Abbott Laboratories | $138.97 | 2021-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $120.89 | 2021-2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $119.09 | 2019-2025 | |
| Lilly USA, LLC | $108.97 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $104.40 | 2020-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $99.94 | 2019-2024 | Vaxneuvance, Gardasil, Capvaxive |
| Medtronic, INC. | $99.45 | 2025 | Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $94.13 | 2019-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.